MAPK1:Alzheimer disease, activation of MAPK activity, apoptotic process, axon guidance, long-term synaptic potentiation, Activation of NMDA receptor upon glutamate binding and postsynaptic events. This evidence concerns the gene MAPK1 and early-onset autosomal dominant Alzheimer disease.